RxDoctor Payments Data

Zachary Morie

Family Medicine · Newport News, VANPI 1730611245

Payments from drug & device makers

$551in general payments, 2019–2025

Across 29 payments — averaging $19.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$158
  • Boston Scientific$95
  • Pfizer$83
  • AbbVie$45
  • Amgen$33
  • Takeda Pharmaceuticals U.S.A., Inc.$30
  • plus $107 from 6 others

What the payments were for

  • Food & beverage$53096%
  • Education$214%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$551 in reported general payments places this provider in the 60th percentile of 2,553 family medicine providers in Virginia.

See all family medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$225,474
Medicare patients
401
Services billed
6,281

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide115$141,669
OzempicSemaglutide94$129,773
JardianceEmpagliflozin118$125,258
EliquisApixaban64$73,950
XareltoRivaroxaban41$58,847
JanuviaSitagliptin Phosphate31$40,635
FarxigaDapagliflozin Propanediol18$23,684
JanumetSitagliptin Phos/Metformin Hcl15$19,981
MyrbetriqMirabegron14$18,030
Trelegy ElliptaFluticasone/Umeclidin/Vilanter25$17,483
WegovySemaglutide11$14,582
RybelsusSemaglutide15$14,294
Combivent RespimatIpratropium/Albuterol Sulfate23$13,934
Spiriva RespimatTiotropium Bromide18$12,249
Incruse ElliptaUmeclidinium Bromide16$11,304

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Wegovy, Rybelsus$24$158,649120 claims
Lilly USA, LLCTrulicity$23$141,669115 claims
PfizerEliquis$83$73,95064 claims
GSKTrelegy Ellipta, Incruse Ellipta, Anoro Ellipta$17$39,07461 claims
AbbVieSynthroid$45$3,20971 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,553 family medicine providers in Virginia.

Other family medicine in Newport News

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →